midfest.info

Join-Us | Log-In

Media | Translate

Make a Comment • Email Link • Send Letter to Editor

IPFS News Link • Science, Medicine and Technology

A Call To Rein In Phase III Trials

04-01-2014 • arclein

We estimate that development costs for drugs could be reduced by as much as 90%, and the time required by 50%, if the threshold for initial approval were defined in terms of efficacy and fundamental safety. Cutting costs and time, while requiring high-quality and transparent patient registries for independent safety monitoring, would be a more informative and cost-effective approach. With the widespread adoption of electronic health records a

midfest.info

FreedomsPhoenix.com

The domain and name of this website are servicemarks of Ernest Hancock.
Website is Copyright © 2025 by Ernest Hancock. All rights reserved worldwide.
PO Box 1232, Tonopah, AZ 85354 USA.

Stats by StatCounter